Skip to main content
Equibles

Edward G. Broenniman

Chairman

Aethlon Medical Inc (AEMD)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Edward G. Broenniman

Edward G. Broenniman is recorded as Chairman at Aethlon Medical Inc (AEMD). Aethlon Medical Inc reported in an 8-K filed October 1, 2026 that Edward G. Broenniman was appointed director, effective October 1, 2026. Aethlon Medical Inc reported in an 8-K filed February 23, 2026 that Edward G. Broenniman was appointed director, effective February 19, 2026. Aethlon Medical Inc reported in an 8-K filed October 2, 2024 that Edward G. Broenniman was appointed director, effective September 27, 2024. Equibles holds 4 filed executive changes naming Edward G. Broenniman; each is listed under recent activity with its source filing.

“The Company’s stockholders elected five directors, each to hold office until the Company’s next annual meeting of stockholders, or until their successors are duly elected and qualified, subject to prior death, resignation, or removal, as follows:”
Aethlon Medical Inc Form 8-K, filed October 1, 2026 · Read the filing
“The Company's stockholders elected five directors, each to hold office until the Company's next annual meeting of stockholders, or until their successors are duly elected and qualified, subject to prior death, resignation, or removal, as follows:”
Aethlon Medical Inc Form 8-K, filed February 23, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Aethlon Medical Inc

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.